Andaman7 shares insights on eClinical with leading industry journal : Applied Clinical Trials Magazine
Are you interested in new developments that are shaping today’s eClinical market?
Vincent Keunen, founder and CEO of Andaman7, shares his view with Applied clinical Trials Magazine AppliedClinicalTrialsMagazine on how to seize opportunity as technologies merge.
Vincent looks at next generation mobile technologies and applications that are revolutionizing the way we think about clinical research.
He talks about the value of interoperability and collaboration to take eClinical to the next level. Highlighting that improved usability is key for efficiency, Vincent shares Andaman7’s view on the ultimate endgame: Technology that works across all data types, protocols, sources, and formats to bring:
-
Enhanced research and care coordination across all therapies.
-
Empowered patients;
-
Measurable outcomes (for medical research);
-
Managed disease (for care stakeholders).
To learn more about Andaman7’s full range of solutions, visit Andaman7 website or contact B2B@andaman7.com
Andaman7 is the most advanced platform to run your decentralized or hybrid clinical trial. We make it easy to collect digital data from patients while respecting the GDPR and HIPAA. Besides privacy regulations, Andaman7 is also validated for FDA 21 CFR part 11 and EU Annex 11.
